HERE ARE THE TOP TEN MOLECULAR DIAGNOSTICS COMPANIES, ranked by revenues from international sales of clinical molecular products during 2004. Collectively, these ten firms generated total revenues of $1.74 billion. By itself, Roche Diagnostics represents 40% of this market. One reason for this large number is the revenues generated by the PCR patents the company […]
- "Molecular IVD Rankings"
Top Ten Clinical Molecular Companies
Assessing Growth in Molecular Diagnostics
- By Robert Michel
- > From the Volume XII No. 13 - September 12, 2005 Issue
